Food and Drug Administration on Monday Granting of permission for emergency use of the Pfizer-BioNTech vaccine For use in teens ages 12 to 15 who have become the first vaccinations to receive this type of vaccination in the United States
The decision means teens ages 12 to 15 can qualify for the injection as soon as Thursday, after a meeting of the Centers for Disease Control and Prevention advisory committee on Wednesday. President Joe Biden said last week that 20,000 pharmacies were ready to start vaccinating teens as soon as necessary approvals were obtained.
The president said the shots will also soon be available through pediatricians’ offices. “And if the teens are on the go this summer, they can get their first shot in one place and a second shot elsewhere.”
In fact, that might be more complicated. FDA officials who spoke late Monday said that although their permit covers the entire country, each state may have its own rules about who can give vaccines, so not all pharmacies or vaccination sites will be available for adults. Open to teenagers.
Older teens, ages 16 to 17, have been allowed to get the Pfizer-BioNTech vaccine since it was licensed in December. The other two vaccines licensed for use in the USA, from Moderna and Johnson & Johnson, have not been available for minors because studies are still ongoing.
Also in the news:
The World Health Organization has identified the B.1.617 variant that was first detected in India as’A variant of anxietyIndia is experiencing a deep epidemic crisis as the substitute is spreading across the country, which has since been found in 32 countries including the United States.
The President of El Salvador has said that he will donate coronavirus vaccines to seven towns in Honduras despite the fact that vaccination efforts in his country are still struggling.
► Publix pharmacies are now accepting entry to COVID-19 vaccine in all locations across seven states – Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee and Virginia.
New York State positive rate It fell to its lowest level since before HalloweenState and federal records show that new cases fell 26% last week compared to the previous week.
📈 Today’s numbers: The United States has more than 32.74 million confirmed cases of coronavirus and 582,100 deaths, According to data from Johns Hopkins University. Global totals: More than 158.6 million cases and 3.29 million deaths. More than 329.8 million vaccine doses have been distributed in the United States and more than 261.5 million doses have been administered. According to the CDC. More than 115.5 million Americans are fully vaccinated – 34.8% of the population.
📘 what we read: A year full of social distancing, wearing masks, washing hands, and staying at home to prevent the spread of the Corona virus, made the 2020-2021 flu season practically non-existent. Read more here.
Fifteen months after the pandemic closed most of the world, researchers are still trying to determine this How much a person needs a certain type of antibody To avoid serious illness, hospitalization, or death. It’s something that scientists all over the world will find very useful as more vaccines and potential boosters are created. The information will help show whether the vaccine is effective enough quickly, without the need for large-scale, lengthy trials.
“All you have to do is vaccinate people with a new vaccine, measure their antibodies, and you’re done,” says biostatist Dr. Peter Gilbert. “And you could do that with maybe 400 people instead of 40,000.”
– Elizabeth method
The Ministry of Education will allocate $ 36 billion to colleges nationwide to help universities and students grappling with the pandemic. The money is part of the US rescue plan, and half of the funding aims to go directly to the students.
In addition to direct grants, the ministry said colleges could use the funds to retain students or help re-enroll those who dropped out due to the pandemic. Colleges can also use the funds to help vaccinate students or prevent the spread of the Coronavirus on campus. Not-for-profit public and private universities can use some of the funding to offset costs related to the pandemic such as lost revenue or expenses associated with providing online education or training faculty and staff. For-profit colleges must direct all the money they receive to students.
International students and DACA recipients have been excluded from former emergency funding under former President Donald Trump. In a call with reporters Monday evening, Education Minister Miguel Cardona said relief funding would now include all students.
President Joe Biden will speak with three Democratic governors and three Republican governors on Tuesday Creative ways to pollinate more people. Biden will hypothetically meet with the leaders of Ohio, Utah, Massachusetts, Maine, Minnesota and New Mexico to share best practices as the administration moves toward its goal of having at least 70% of adults partially vaccinated by July 4.
More than half of all residents in Massachusetts, Maine and New Mexico have had at least one shot, ranking it in the top 10. Ohio and Utah are in the lower half of the states for vaccination rates.
Novavax, a Maryland-based biotechnology company whose vaccine has done well in clinical trials in the UK and South AfricaShe expects to publish data on her US study “within a few weeks.” But it won’t be ready for regulatory approval until sometime in the second half of the year. Executive Director Stanley Erk told USA TODAY that Novavax has been addressing production issues that have prevented the company from manufacturing the vaccine on a large scale, and that it remains “on the right track” to apply for an emergency use permit with the Food and Drug Administration.
In a quarterly report released MondayNovavax said it intends to seek this clearance as well as approval from European regulatory agencies by the third quarter. The company has also cut its projected capacity to 100 million doses per month by the end of September. Novavax has a production and manufacturing deal with the Serum Institute in India and its vaccine is widely expected in developing countries.
Contribution: Karen Weintraub, USA Today; Associated Press